22 Nov

HealthBeacon Announces New Round of Investment Funding

Dublin based med tech company, HealthBeacon, this morning announced the company is embarking on a new round of investment funding seeking €5m before 2018 year end.

The announcement was made at “Investing in Digital Health” a major private investor event hosted by the digital health company earlier this morning. The breakfast event in Royal College of Physicians gathered authorities from medical tech, med entrepreneurs, investment trailblazers and medical experts from all over Ireland.

A keynote presentation regarding “Emerging Trends and impact of Digital and Connected Heath” was delivered by Chandana Fitzgerald, Medical Lead, HealthXL.

HealthBeacon designed “Investing in Digital Health” to bring together some of the most forward thinking technology and healthcare minds to discuss the growth and opportunity for investing in digital health around the panel discussion on ‘Emerging trends and impact of connected health’ – from a Global Perspective.

‘We believe that investing in Digital Health not only substantially improves patient outcomes and delivers a return for national health systems, it creates new employment and investor returns also. Ireland is building on its reputation in the Life Sciences and Medtech arenas by now producing quality Digital Health companies such as Health Beacon that are capable of competing Internationally. We see this as a major area of interest going forward.’ Liam Kiely of Cantor Fitzgerald

Event panellists, led by Mike Ryan, Founding Director of Irrus Investments as panel moderator included Jim Joyce CEO HealthBeacon, Conor Hanley, CEO, Fire1 and Rosanne Longmore, CEO Coroflo who were recently awarded €250,000 from Enterprise Ireland and successfully raised €900,000 within its first six months.

We are excited to announce HealthBeacon’s next investment phase, as we continue to move towards global connection of healthcare through assisting in clever patient medication management and revolutionizing medication adherence.   Our technology provides powerful insights for medics by providing real world patient data.  Jim Joyce, CEO, HealthBeacon

To date HealthBeacon has raised over €3m with current investors including Elkstone Partners and Oyster Capital.

HealthBeacon were recently awarded ‘Pharma Project of the Year – Large’ at the Pharma Industry Awards 2017.  HealthBeacon announced the creation of 20 new jobs for the Dublin based digital health earlier this year.

The “Smart Sharps System” helps patients adhere to their medication schedule. Current estimated costs to manage medication non-adherence is estimated to be $290 billion in the US market alone. The use of HealthBeacon smart technology aims to make a dramatic impact to cost savings within the healthcare industry. The expansion of the platform will provide access to the technology globally in Europe, North America, South America and the Middle East.

 
24 Oct

Funding and Scaling Series

HealthBeacon CEO, Jim Joyce participated in a “fire side chat” at an investment event for the “Funding and Scaling Series” in Dublin on Tuesday. The event is being hosted by Dublin Business Innovation Centre (Dublin BIC) which provides business consultancy services to early stage, high potential start-ups.

As a serial entrepreneur, Jim was asked to present to the crowd of 300-400 attendees comprised of entrepreneurs, investors and business leaders due to his success in raising funds as HealthBeacon has successfully completed two rounds of funding in the last three years and will be seeking a third round of funding in the coming months.

The event is part of the Dublin BIC Funding and Scaling series, a quarterly breakfast briefing, which was introduced by Dublin BIC in November last year. These briefings offer entrepreneurs the opportunity to explore different approaches to fundraising and scaling for start-ups. It involves hearing the perspectives of investors and learning from those that have successfully funding and scaled their business.

In addition to the presentation regarding his own success, from start-up to scale-up, Jim will join a panel of entrepreneurial peers to answer questions that prepare start-ups for potential investment.

20 Oct

HealthBeacon Builds Bridges into Latin American Market

Over the next few quarters, HealthBeacon will embark on several strategic initiatives to expand our global influence and educate new markets about our award-winning technology. As part of HealthBeacon’s global growth initiatives, we were proud to welcome several key influencers from Latin America into the HealthBeacon Dublin headquarters.  The HealthBeacon team was joined by Doctor Valéria Camargo, Medical Director of Auditing, OMINT, Mr. Márcio do Lago, Executive Director, ABCIS (Brazilian Association of CIOs) and Mr. Aimar Tarrufi, Senior Claims Director, SUL AMERICA. Also joining the team in Dublin was our LATAM manager, Andrea Rangel who is based in our São Paulo facility.

The delegates took part in a workshop to learn about the HealthBeacon technology and the potential for connected medicine in Latin America. The LATAM market has a large patient base where Brazil alone could serve millions of patients afflicted with diseases where biologic treatments are used. The workshop participants brought a global perspective for medical technology, healthcare, pharmaceutical, health insurers and information technology to discuss the future of connected medicine and digital therapies. Furthermore, these senior decision makers have a particular expertise in Brazil in health insurance and the use of health information technology to improve the support of patients in the community. The Brazilian health insurance market is one of the most dynamic in the adoption of new technologies to improve therapeutic outcomes. Brazil’s population is spread over one of the world’s largest land masses and supporting patients who are far away from hospital is a key priority in improving outcomes of community health.

In addition to the private workshop at HealthBeacon, the delegates participated in the Enterprise Ireland event “Med in Ireland” which is Ireland’s largest medical technologies event and a high-profile showcase for the entire spectrum of the Irish medical technologies sector.

31 Jul

HealthBeacon featured in Sunday Times

HealthBeacon was featured in The Sunday Times on July 30th, about the advances and growth in the health technology industry. “Shot in the arm for medtech recruits: Health technology has made huge advances and now provides an array of rewarding job prospects.” By Sorcha Corcoran

“With the increasing use of digital technology in healthcare a number of med-tech start-up companies have emerged which are growing and hiring. These include HealthBeacon in Dublin and Nova Leah and Diaceutics in Dundalk.

HealthBeacon has designed a special bin for patients who self-inject medications at home. It is digitally connected and programmed with their personal medication schedule and uses customised reminders to help them stay on track with their medication. Founded in 2013, the company is looking to take on 20 people in Dublin.

‘We plan to hire people for a wide array of roles including product development, engineering and project management,’ said HealthBeacon’s marketing director, Brie Kelly.  ‘In a little over a year, we have grown from the founders to 17 employees and we expect very high growth over the next five years.’ Kelly moved from Arizona to work for HealthBeacon nine months ago. A marketing graduate, she previously worked for Banner Health, which operates 28 hospitals and facilities across six US states. HealthBeacon’s chief executive and co-founder Jim Joyce was born and raised in Boston and the company opened an office there last March.”

 

26 Jun
22 Jun
06 Jun

Prime Minister / HealthBeacon global announcement

Prime Minister and HealthBeacon make global employment announcement

(Chicago, Dublin June 6th, 2017) Today, An Taoiseach Enda Kenny and HealthBeacon CEO Jim Joyce release a joint announcement about the addition of 20 new jobs in 2017 for the HealthBeacon team. This announcement came during the Enterprise Ireland market visit in Chicago and was featured in Irish media outlets.

Jim Joyce - CEO at HealthBeacon

Prime Minister and HealthBeacon make global employment announcement
01 Jun

HealthBeacon – Finalist for Innovation Awards

HealthBeacon Named as Finalist for Irish Times Innovation Awards

(Dublin, June 1st, 2017) Today, HealthBeacon was named as a finalist for the Irish Times Innovation award in the category of Life Sciences and Healthcare.

According to the Irish Times, having made it through the first round of judging, finalists will now present to a distinguished panel of senior business leaders at an event at the Royal Hospital Kilmainham next month. The seven-category award winners and overall Innovation award will be presented at a gala event in October.

HealthBeacon - finalist at the Irish Times Innovation Awards

01 Jun

HealthBeacon Named One to Watch

(Dublin, May 31, 2017) HealthBeacon was recognised today as a start-up to watch for life sciences by the Silicon Republic.

“The new rockstars of science and technology aren’t creating social networks or mobile apps per se, they are occupied with the science of living, developing life-saving and life-enhancing solutions, services, drugs, medtech devices and analytical systems.”

HealthBeacon is delighted to be recognised for the impact we can have on the vital issue of medical adherence. At a time when patient experience is more important than ever, we strive to make medication management as easy as possible.

Kieran Daly, Dave Shanahan, Jim Joyce

HealthBeacon Named One to Watch
21 Mar

HealthBeacon Grand Opening USA

HealthBeacon Ribbon CuttingBoston, Mass., March, 17, 2017–Medical technology is growing in Boston and for good reason:

Connected medicine is revolutionizing medication adherence. Jim Joyce, creator of the HealthBeacon, believes that connecting real life data about a patient’s behaviour can provide powerful clinical insights and targeted interventions to improve treatment and outcomes. Enter a smart tool for managing medication, the flagship product: The HeathBeacon.

HealthBeacon officially opened their third office at 423 W. Broadway in South Boston, MA on Thursday, March 16th, 2017.  The ceremonial ribbon cutting was performed by Irish Minister Katherine Zappone TD, Minister for Children and Youth Affairs, and accompanied by Fionnuala Quinlan, Consulate General and her team.  This expansion will allow for a North American hub that delivers Irish technology, manufactured in Dublin and exporting it to the world. What better way to drive medical technology growth and development between countries than to have an Irish-American serial entrepreneur leading the way?

Born and raised in Boston, MA, Joyce saw the opportunity that Dublin provides innovative start-up companies. After working several years for a multinational, Joyce decided to venture out on his own and made his first foray into entrepreneurship. His first company, Point of Care, was established in Dublin with the goal of transforming the way patients experience medical treatments in their community. Joyce explains that it was this venture that gave him the idea for the HealthBeacon. He explains “I was originally trying to figure out a way to manage waste disposal and costs, and fumbled my way to an idea that can fundamentally change the pharmaceutical industry.”

HealthBeacon’s digital platform exploits the increased trend in healthcare to connect devices and data for better health delivery. Co- Founder of HealthBeacon, Kieran Daly explains “At HealthBeacon we believe that technology should be near invisible and sophistication should be masked by simplicity. When we thought about how to develop our medical adherence tools we wanted to make sure that the patient experience was frictionless but the impact was meaningful.” It is this seamless connectivity that is driving the internet of things (IoT) trend, and will drive fast adoption and scaling of the platform, especially as it supports lower cost health delivery.

The New England Healthcare Institute estimates that 290 billion dollars is spent each year because of poor medication adherence. Evidence also suggests that patients on average comply with their medication only 52% of the time without digital intervention. Recent studies show that those patients using digital intervention are compliant 77% of the time. We believe that it is this evidence that has led to HealthBeacon’s being embraced by both clinicians and patients.

According to Jim Joyce, “This is the perfect location for an Irish company to launch into the US market. Our Boston team will provide critical technical development and support to pharmaceutical and biotech companies looking to digitally connect their medicines.”

Tim Connelly, Executive Director of the Massachusetts Technology Collaborative, a public economic development agency which promotes the digital health sector across Massachusetts, highlighted the importance of HealthBeacon’s addition to Boston.

“Massachusetts is home to more than 350 digital health organizations working at the intersection of health care and technology,” stated Connelly. “HealthBeacon will find a welcome community of innovators and entrepreneurs, both in healthcare and technology, who can help the company develop, market, and grow their innovative products. As a leading state in healthcare policy, we welcome with open arms companies like HealthBeacon that are working to enhance the delivery of care and ultimately to better the lives of patients.”